Advertisement
ICUI vs INFU
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Buy and INFU is a Hold.
Aroon Indicator for ICUI shows an upward move is likely
ICUI's Aroon Indicator triggered a bullish signal on October 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 205 similar instances where the Aroon Indicator showed a similar pattern. In 155 of the 205 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Indicator exited the oversold zone, 22 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on ICUI as a result. In 63 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on September 24, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 36 of 51 cases over the following month. The odds of a continued upward trend are 71%.
ICUI moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 193 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 59 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
ICUI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.956) is normal, around the industry mean (4.961). ICUI has a moderately high P/E Ratio (140.275) as compared to the industry average of (37.232). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
INFU in +6.19% Uptrend, growing for three consecutive days on October 20, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INFU advanced for three days, in 173 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for INFU just turned positive on October 20, 2026. Looking at past instances where INFU's MACD turned positive, the stock continued to rise in 38 of 61 cases over the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 88 of 138 cases where INFU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The 10-day RSI Indicator for INFU moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 20 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
INFU broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.731) is normal, around the industry mean (2.874). P/E Ratio (33.452) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.817) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
ICUI | INFU | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 87 Overvalued | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 92 | |
SMR RATING 1..100 | 89 | 56 | |
PRICE GROWTH RATING 1..100 | 41 | 36 | |
P/E GROWTH RATING 1..100 | 96 | 62 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INFU's Valuation (81) in the Medical Specialties industry is in the same range as ICUI (87). This means that INFU’s stock grew similarly to ICUI’s over the last 12 months.
INFU's Profit vs Risk Rating (92) in the Medical Specialties industry is in the same range as ICUI (100). This means that INFU’s stock grew similarly to ICUI’s over the last 12 months.
INFU's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for ICUI (89). This means that INFU’s stock grew somewhat faster than ICUI’s over the last 12 months.
INFU's Price Growth Rating (36) in the Medical Specialties industry is in the same range as ICUI (41). This means that INFU’s stock grew similarly to ICUI’s over the last 12 months.
INFU's P/E Growth Rating (62) in the Medical Specialties industry is somewhat better than the same rating for ICUI (96). This means that INFU’s stock grew somewhat faster than ICUI’s over the last 12 months.
| ICUI | INFU | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 69% | 1 day ago 87% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 68% | N/A |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 62% |
| TrendWeek ODDS (%) | 1 day ago 69% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 74% |
| Advances ODDS (%) | 11 days ago 68% | 3 days ago 66% |
| Declines ODDS (%) | 2 days ago 71% | 22 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 76% | 1 day ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICUI’s FA Score shows that 0 FA rating(s) are green while INFU’s FA Score has 0 green FA rating(s).
- ICUI’s FA Score: 0 green, 5 red.
- INFU’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICUI’s TA Score shows that 6 TA indicator(s) are bullish while INFU’s TA Score has 3 bullish TA indicator(s).
- ICUI’s TA Score: 6 bullish, 3 bearish.
- INFU’s TA Score: 3 bullish, 4 bearish.
Price Growth
ICUI (@Pharmaceuticals: Other) experienced а +0.66% price change this week, while INFU (@Medical/Nursing Services) price change was +3.31% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
ICUI is expected to report earnings on Nov 05, 2026.
INFU is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.59% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ICUI and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
|---|---|---|---|---|
| ICUI | 100% | +4.66% | ||
| CLPT - ICUI | 57% Loosely correlated | N/A | ||
| ALGN - ICUI | 50% Loosely correlated | +2.74% | ||
| MMSI - ICUI | 50% Loosely correlated | +2.78% | ||
| A - ICUI | 50% Loosely correlated | -2.17% | ||
| BLCO - ICUI | 49% Loosely correlated | +1.46% | ||
More | ||||
INFU and
Correlation & Price change
A.I.dvisor indicates that over the last year, INFU has been loosely correlated with AMIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then AMIX could also see price increases.
| Ticker / NAME | Correlation To INFU | 1D Price Change % | ||
|---|---|---|---|---|
| INFU | 100% | +0.64% | ||
| AMIX - INFU | 43% Loosely correlated | -2.72% | ||
| VREX - INFU | 42% Loosely correlated | -0.05% | ||
| ICUI - INFU | 39% Loosely correlated | +4.66% | ||
| BFLY - INFU | 38% Loosely correlated | -4.08% | ||
| ANIK - INFU | 33% Loosely correlated | +2.38% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBIH | 25.28 | 0.14 | +0.58% |
| iShares iBonds Oct 2031 Term TIPS ETF (IBIH) | |||
| TDTT | 23.53 | 0.10 | +0.43% |
| Northern Trust iBoxx 3-Year Target Duration TIPS ETF (TDTT) | |||
| DFEB | 51.79 | -0.25 | -0.48% |
| FT Vest U.S. Equity Deep Buffer ETF - February (DFEB) | |||
| AIUP | 27.95 | -1.23 | -4.20% |
| Finq First U.S. Large Cap AI Managed Equity ETF | |||
| QTAC | 23.51 | -1.15 | -4.67% |
| Q3 All-Season Tactical Advantage ETF (QTAC) | |||